Abstract
An implantable device comprising a nanochanneled membrane is described. The device uses nanofluidics to control the delivery of diagnostic and/or therapeutic agents intratumorally. The devices can be used for chemotherapy, radiosensitization, immunomodulation, and imaging contrast.
| Original language | English (US) |
|---|---|
| Patent number | US2018125780 |
| IPC | A61M 37/ 00 A I |
| Priority date | 5/16/16 |
| State | Published - May 10 2018 |